Speaker Detail View

Gail K. Naughton, Ph.D., has spent over 30 years extensively researching the tissue engineering process, holds over 105 U.S. and foreign patents, and has founded two regenerative medicine companies. Her current venture, Histogen, is focused on the development of novel solutions based on the products of cells grown under simulated embryonic conditions. Dr. Naughton has brought several tissue engineered products to market including a product for severe burns (TransCyte),a dermal replacement for diabetic ulcers (Dermagraft), an aesthetic dermal filler (Cosmederm/Cosmeplast) and SkinMedica’s TNS product for skin care. At Histogen Dr. Naughton developed a new skin care product which also contains human growth factors, ReGenica, which was recently acquired by Allergan. Dr. Naughton has been extensively published and a frequent speaker in the field of tissue engineering and regenerative medicine.